Skip to content
Peptigraph home
Shop Peptides50% off*

hCG Benefits: Claims vs What Studies Show

Benefits people claim for hCG, set against what published studies measured, and where no study exists.

Medical review pendingGonadotropinUpdated
Strongest evidence
Human RCT
Human / animal studies
11 / 0
in our evidence file (PubMed search, 11 Oct 2026)
FDA status
Approved (prescription only)

Claimed benefits and what studies show

Each row is an area where people claim a benefit, with the strongest study we summarise behind it. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

hCG claimed benefits and the studies behind them
ClaimBest evidenceStudies (human / animal)What was measuredPage
TestosteroneHuman RCT evidence, 4 of 48 / 0Testosterone response; Spermatogenesis; Sperm production with hCG/hMGEvidence for testosterone
Weight lossHuman RCT evidence, 4 of 44 / 0Lean body mass and fat mass; Weight loss vs placebo; Body compositionEvidence for weight loss
Muscle growthHuman RCT evidence, 4 of 42 / 0Lean body mass and fat mass; Muscle strength and function; Body compositionEvidence for muscle growth
BodybuildingHuman RCT evidence, 4 of 41 / 0Serum testosterone after a single dose; Management of steroid-induced hypogonadismEvidence for bodybuilding

Strongest study per claim: Testosterone, Clinical endocrinology 2024, PMID 38446525; Weight loss, The Journal of clinical endocrinology and metabolism 2002, PMID 12107212; Muscle growth, The Journal of clinical endocrinology and metabolism 2002, PMID 12107212.

What the studies measured

hCG outcomes in published studies
OutcomeResultStudy typeSource
Testosterone responseUrinary and recombinant hCG gave similar testosterone peaks and timing, apart from a mildly lower early (<48 h) response with urinary.Human RCTClinical endocrinology 2024, PMID 38446525
Spermatogenesis23 of 30 subjects achieved spermatogenesis, median time 12 months.Human RCTn = 30Endocrine practice 2024, PMID 39025301
Sperm production with hCG/hMGSperm produced in 26/103 (25.24%) on hCG/hMG versus 62/117 (52.99%) on GnRH pulse therapy.Human RCTn = 220Medicine 2019, PMID 31374027
TestosteroneTestosterone rose in all groups to a final mean of 5.17 nmol/L (223% increase) with no difference between hCG, clomiphene or both.Human RCTn = 282BJU international 2018, PMID 29772111
Sperm concentration >= 1.0 x 10(6)/mL51.5% (17/33) continual and 55.9% (19/34) sequential FSH/hCG reached sperm concentration of at least 1.0 x 10(6)/mL.Human RCTn = 67The Journal of clinical endocrinology and metabolism 2015, PMID 25825944
Serum testosterone after a single doseBoth recombinant hCG doses raised serum and urine testosterone and suppressed LH in healthy men.Human RCTClinical endocrinology 2009, PMID 19170708
Lean body mass and fat massLean body mass rose by about 2 kg (P < 0.001), body weight about 1 kg and fat mass fell about 1 kg (P < 0.05).Human RCTn = 40The Journal of clinical endocrinology and metabolism 2002, PMID 12107212
Muscle strength and functionMuscle strength was not significantly increased.Human RCTn = 40The Journal of clinical endocrinology and metabolism 2002, PMID 12107212
Testis volumeTestis volume fell by about 5 ml (P < 0.05).Human RCTn = 40The Journal of clinical endocrinology and metabolism 2002, PMID 12107212
Weight loss vs placebohCG showed no advantage over placebo for any recorded variable in obese women on a diet.Human RCTn = 40South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1990, PMID 2405506
Weight loss vs placeboNo significant difference in weight loss, waist/hip circumference or hunger between hCG and placebo.Human RCTn = 51The American journal of clinical nutrition 1976, PMID 786001
Body compositionhCG treatment lowered insulin resistance, triglycerides, body fat ratio and waist-to-hip ratio and raised fat free mass in IHH.Human uncontrolled trialn = 16Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2016, PMID 26485362
Spermatogenesis and pregnancyGonadotropin therapy induced spermatogenesis in 74% (mean 11.8 months) and pregnancy in 52% of couples with a child wish.Meta-analysisn = 1583Andrology 2026, PMID 41987691
Dual vs hCG aloneCombined gonadotropin therapy beat hCG monotherapy.Meta-analysisn = 1583Andrology 2026, PMID 41987691
Spermatogenesis hCG alone vs hCG + FSHSpermatogenesis 86% with hCG + FSH versus 40% with hCG alone.Meta-analysisn = 5328European journal of endocrinology 2024, PMID 38128110
Spermatogenesis success rateGonadotropin therapy achieved spermatogenesis in 75% (69-81) of men with HH.Meta-analysisAndrology 2014, PMID 25271205
Management of steroid-induced hypogonadismThe review lists hCG among management strategies for anabolic steroid-associated hypogonadism; no quality trials met inclusion.ReviewFertility and sterility 2014, PMID 24636400
Efficacy in obesityMeta-analysis found no scientific evidence that hCG is effective for obesity.Meta-analysisBritish journal of clinical pharmacology 1995, PMID 8527285
Not shown in any study we cite. Searches behind this page: PubMed search on 2 Oct 2026 for “("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (hypogonadism[tiab] OR "male infertility"[tiab] OR hypogonadotropic[tiab] OR testosterone[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt])”: 97 results. PubMed search on 2 Oct 2026 for “("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (obesity[tiab] OR "weight loss"[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt] OR systematic review[pt])”: 11 results. PubMed search on 2 Oct 2026 for “("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (testosterone replacement[tiab] OR TRT[tiab] OR "anabolic steroid"[tiab] OR bodybuilder*[tiab] OR "lean body mass"[tiab] OR "muscle"[tiab]) AND humans[mh]”: 260 results. PubMed search on 2 Oct 2026 for “("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) AND men[tiab] NOT pregnan*[tiab]”: 9 results.

What hCG is approved for, per its labels

The Novarel label lists prepubertal cryptorchidism and hypogonadotropic hypogonadism in males, plus ovulation induction, as the uses.[23]

Both labels open their indications with a capitalised statement that hCG has not been demonstrated to be effective adjunctive therapy in obesity.[24]

Testosterone and muscle claims against the trials

In men with hypogonadism, hCG injections twice weekly raised testosterone with no significant difference from clomiphene or the combination.[4]

In older men with partial androgen deficiency, recombinant hCG raised lean body mass by about 2 kg.[7]

Strength did not follow: the same older-men trial found shoulder and knee strength was not significantly increased.[7]

In men with idiopathic hypogonadotropic hypogonadism, gonadotropin replacement therapy was reported to decrease triglycerides and increase fat-free mass.[10]

The weight-loss claim in controlled trials

In a double-blind trial in obese women, hCG did not enhance weight loss compared with placebo on the same diet.[9]

A second placebo-controlled trial in obese women found no advantage for hCG on any recorded variable.[8]

A dated PubMed count (2026-10-02) finds 156 human-only and 124 animal records for hCG with weight terms; the large number reflects volume of writing rather than a demonstrated effect.

Calculated from goals file our PubMed count ledger; goal weight-loss; peptide hcg; query (("human chorionic gonadotropin"[tiab] OR "chorionic gonadotropin"[tiab] OR "chorionic gonadotrophin"[tiab] OR hCG[tiab] OR choriogonadotropin[tiab]) NOT (pregnan*[tiab] OR trophoblast*[tiab] OR choriocarcinoma[tiab] OR "germ cell"[tiab] OR hydatidiform[tiab] OR "embryo transfer"[tiab] OR oocyte*[tiab] OR "in vitro fertilization"[tiab] OR IVF[tiab] OR "ovarian stimulation"[tiab] OR "ovulation induction"[tiab] OR "ovarian hyperstimulation"[tiab] OR equine[tiab] OR eCG[tiab] OR "pregnant mare"[tiab])) AND ("weight loss"[tiab] OR "weight reduction"[tiab] OR "body weight"[tiab] OR obes*[tiab] OR overweight[tiab] OR adiposity[tiab] OR "fat mass"[tiab] OR "body fat"[tiab] OR "fat loss"[tiab]); date 2026-10-02; human only 156; animal 124. Formula: count of PubMed records for the dated query with the stated filter (humans not animals, and animals not humans)

Bodybuilding use and its context

A doping-control study begins from the point that administering gonadotrophins is prohibited in sport.[6]

A case report describes a young woman admitted with ischaemic stroke after recent hCG use in a weight loss regimen, and notes thromboembolic risk with misuse.[25]

More on hCG

DosageSide effectsResultsHow it works

Common questions

Is hCG proven to work?

The strongest study we summarise for hCG is human rct evidence, among 17 studies. A trial result is not an approval; see the legal status.

What does hCG do?

The Novarel label says its action is virtually identical to pituitary luteinizing hormone, with a small degree of FSH activity.[23]

Is hCG good for weight loss?

Two placebo-controlled trials in the cached set found no advantage over placebo; one concluded there is no rationale for hCG injections in obesity.[8]

More on hCG

DosageDoses used in published studies, with the source for each.CalculatorVial, water and dose to syringe units.Side effectsWhat labels and studies report, and what is unknown.ResultsStudy outcomes and when they were measured.PricePrice per mg and per week from dated listings. No vendor links.How it worksTarget, mechanism and how long it acts, from the label or studies.

Sources

  1. 1Single and multi-dose pharmacology of recombinant and urinary human chorionic gonadotrophin in men.Clinical endocrinology · 2024PMID 38446525Accessed 2 Oct 2026
  2. 2Effect of Combined Low Dose Human Gonadotropic Hormone, Follicle Stimulating Hormone, and Testosterone Therapy (LFT Regimen) Versus Conventional High Dose Human Gonadotropic Hormone and Follicle Stimulating Hormone on Spermatogenesis and Biomarkers in Men With Hypogonadotropic Hypogonadism.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2024PMID 39025301Accessed 2 Oct 2026
  3. 3Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism.Medicine · 2019PMID 31374027Accessed 2 Oct 2026
  4. 4Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: a short-course randomized study.BJU international · 2018PMID 29772111Accessed 2 Oct 2026
  5. 5Sequential Versus Continual Purified Urinary FSH/hCG in Men With Idiopathic Hypogonadotropic Hypogonadism.The Journal of clinical endocrinology and metabolism · 2015PMID 25825944Accessed 2 Oct 2026
  6. 6Effects of recombinant human LH and hCG on serum and urine LH and androgens in men.Clinical endocrinology · 2009PMID 19170708Accessed 2 Oct 2026
  7. 7A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency.The Journal of clinical endocrinology and metabolism · 2002PMID 12107212Accessed 2 Oct 2026
  8. 8Human chorionic gonadotrophin and weight loss. A double-blind, placebo-controlled trial.South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde · 1990PMID 2405506Accessed 2 Oct 2026
  9. 9Ineffectiveness of human chorionic gonadotropin in weight reduction: a double-blind study.The American journal of clinical nutrition · 1976PMID 786001Accessed 2 Oct 2026
  10. 10The Effects of Gonadotropin Replacement Therapy on Metabolic Parameters and Body Composition in Men with Idiopathic Hypogonadotropic Hypogonadism.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2016PMID 26485362Accessed 2 Oct 2026
  11. 11Boosting Male Fertility: The Impact of Gonadotropin Therapy on Hypogonadotropic Hypogonadism-A Systematic Review and Meta-Analysis.Andrology · 2026PMID 41987691Accessed 2 Oct 2026
  12. 12Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis.European journal of endocrinology · 2024PMID 38128110Accessed 2 Oct 2026
  13. 13Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study.Andrology · 2014PMID 25271205Accessed 2 Oct 2026
  14. 14Anabolic steroid-induced hypogonadism: diagnosis and treatment.Fertility and sterility · 2014PMID 24636400Accessed 2 Oct 2026
  15. 15The effect of human chorionic gonadotropin (HCG) in the treatment of obesity by means of the Simeons therapy: a criteria-based meta-analysis.British journal of clinical pharmacology · 1995PMID 8527285Accessed 2 Oct 2026
  16. 16PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (hypogonadism[tiab] OR "male infertility"[tiab] OR hypogonadotropic[tiab] OR testosterone[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt]) (97 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  17. 17PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (obesity[tiab] OR "weight loss"[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt] OR systematic review[pt]) (11 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  18. 18PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (testosterone replacement[tiab] OR TRT[tiab] OR "anabolic steroid"[tiab] OR bodybuilder*[tiab] OR "lean body mass"[tiab] OR "muscle"[tiab]) AND humans[mh] (260 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  19. 19PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) AND men[tiab] NOT pregnan*[tiab] (9 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  20. 20PubMed search: ("human chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (hypogonadism[tiab] OR testosterone[tiab] OR cryptorchidism[tiab] OR "male infertility"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) AND humans[mh] (130 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  21. 21PubMed search: ("chorionic gonadotropin"[tiab] OR hCG[tiab]) AND ("weight loss"[tiab] OR obesity[tiab] OR cryptorchidism[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR thromboembol*[tiab] OR "case report"[pt] OR death[tiab]) (61 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  22. 22PubMed search: ("chorionic gonadotropin"[tiab] OR hCG[tiab]) AND (gynecomastia[tiab] OR "injection site"[tiab] OR hypersensitivity[tiab] OR anaphyla*[tiab]) AND (male[tiab] OR men[tiab] OR boys[tiab]) (95 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  23. 23NOVAREL ® (chorionic gonadotropin) for injection, for intramuscular use Initial U.S. Approval: 1974FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
  24. 24Pregnyl ® (chorionic gonadotropin) for injectionFDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
  25. 25Paradoxical consequence of human chorionic gonadotropin misuse.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2015PMID 25440322Accessed 11 Oct 2026

Found an error? Report a correction.